A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
暂无分享,去创建一个
J. Kane | J. Ouyang | R. Mcquade | W. Carson | R. Sanchez | H. Eriksson | A. Skuban | M. Hobart | S. Pfister | M. Nyilas